National Institutes of Health

TitleOrganizationKeywordsActivity CodeFOALOI Due DateApplication Due Date
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)?National Institutes of Health supplement, meeting, supportR13PA-24-1414/12/2024
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)National Institutes of HealthPopulation assessment, Tobacco and health, Biospecimen accessPAR-24-0274/30/2024
Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)National Institutes of HealthMutant mice, resource centers, research, clinical trials not allowedPAR-24-1055/1/2024
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)National Institutes of HealthNanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-23-2465/3/2024
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)National Institutes of HealthHealth Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresPAR-23-2294/6/20245/6/2024
(NOSI): Promoting Research on Interoception and Its Impact on Health and DiseaseNational Institutes of Health Interoception, R01,R21NOT-AT-21-0025/6/2024
(NOSI): Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population HealthNational Institutes of Health systems science, child health, adolescent health, development, cancer, prevention, disparitiesR01NOT-HD-20-0325/7/2024
Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)National Institutes of Health health disparities, HIV, co-morbidites, population scienceR01RFA-MD-24-0054/7/20245/7/2024
(NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health EffectsNational Institutes of Health Electronic Nicotine Delivery Systems (ENDS), Alternative Nicotine, Tobacco Delivery Systems, Health EffectsR21,R01,Admin Supp,R34,R03,R61/R33NOT-OD-22-0235/8/2024
(NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with DisabilitiesNational Institutes of Health Vaccine Access, Acceptance, Uptake, Children, Adolescents, Pregnant Women, Lactating Women, Persons with DisabilitiesR03 , R21NOT-HD-21-0385/8/2024
Drug Development Tools Research Grants (U01) Clinical Trials OptionalNational Institutes of Healthdevelopment, translational, clinical,RFA-FD-24-0305/13/2024
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)National Institutes of HealthBiomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchPAR-22-0715/17/2024
Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 Clinical Trial Optional)National Institutes of Healthoutcomes, rural, disparities, population science R01RFA-NR-24-0054/17/20245/17/2024
Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials OptionalNational Institutes of HealthDigital health, AI, early detection, clinical, support, U01RFA-FD-24-0375/20/2024
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)National Institutes of HealthHealth Careers Opportunity Program, Cancer Symptom Management, Gene Editing, Cancer Survivorship, TrainingPAR-23-0695/25/2024
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)National Institutes of Healthinvestigator-initiated trial, prevention, dectetion, organ system, translational, genetic, biochemical, PAR-23-2844/25/20245/25/2024
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)National Institutes of HealthTraining, clinical, biomedical, innovation, PAR-23-2785/25/2024
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)National Institutes of HealthTraining, clinical, biomedical, innovation, PAR-23-2775/25/2024
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)National Institutes of HealthTraining, clinical, biomedical, innovation, PAR-23-2765/25/2024
NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)National Institutes of Health aging research, biomedical research, career development, diverse backgrounds, educational activities, health disparities, MSTEM fields, research experiences, underrepresented groupsPAR-24-1354/25/20245/25/2024
NINDS Program Project Grant (P01 Clinical Trial Optional)National Institutes of Healthearly careerP01PAR-24-1694/25/20245/25/2024
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Human Required)National Institutes of Healthearly-stage investigators, basic research, human studies, innovative approaches, high-risk researchPAR-24-0765/29/2024
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)National Institutes of Healthearly-stage investigators, basic research, clinical trials (not allowed), innovative approaches, high-risk researchPAR-24-0755/29/2024
Translational Neural Devices (R61/R33 - Clinical Trial Optional)National Institutes of Health Translational Neural Devices, Clinical Trial OptionalPAR-24-1513/30/20245/29/2024
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)National Institutes of Health support, early career, R16PAR-24-1445/29/2024
Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)National Institutes of Health support, early career, R16PAR-24-1455/29/2024
Maximizing Access to Research Careers (MARC) (T34)National Institutes of Healthearly career, health disparities, workforce development, T34PAR-24-1385/29/2024
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)National Institutes of Healthearly career, health disparities, workforce development, T34PAR-24-1375/29/2024
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional)National Institutes of HealthRegional genomic medicine, eConsult services, clinical trials (optional)RFA-HG-24-0014/30/20245/30/2024
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)National Institutes of Health Building Interdisciplinary Research Careers, Women's Health, BIRCWH, K12 Clinical Trial OptionalRFA-OD-24-0135/30/2024
NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trial Not Allowed)National Institutes of Health early career, health disparities, workforce development, oral, UE5PAR-24-1044/30/20245/30/2024
Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)National Institutes of Healthradiation biodosimetry, assays, triage, predicting health outcomes, acute injuries, delayed injuries, public health emergencyRFA-AI-24-0034/30/20245/31/2024
Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial OptionalNational Institutes of Healthultra-rare cancers, therapeutic development, FDARFA-FD-24-0192/25/20245/31/2024
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)National Institutes of Healthearly -stage, therapeutics, disorders, clincal R61/R33PAR-24-1735/5/20246/4/2024
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)National Institutes of Healthearly -stage, therapeutics, disorders, clincal R33PAR-24-1725/5/20246/4/2024
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)National Institutes of HealthMechanisms, Cancer risk, Incretin mimetics, Clinical trial optionalPAR-23-2795/6/20246/5/2024
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)National Institutes of HealthAnimal models, Translational research, PAR-23-2816/5/2024
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)National Institutes of HealthCancer Health Disparities, Cutting-Edge Technologies, Digital Pathomics, Investigator-Initiated ResearchPAR-23-2456/5/2024
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)National Institutes of HealthNanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-23-2736/5/2024
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)National Institutes of HealthNanotechnology, Brain Disorders, Biomedical Systems, BiomarkersPAR-23-2546/5/2024
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)National Institutes of HealthSBIRT/P, Health Disparities, Clinical Trial, Adult PopulationsPAR-23-2706/5/2024
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)National Institutes of HealthInvestigator-Initiated Research, surgery, PAR-21-3315/6/20246/5/2024
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)National Institutes of HealthCancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research, PAR-21-3226/5/2024
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed)National Institutes of Healthmicrobiome, immune response, novel molecules, PAR-22-0616/5/2024
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)National Institutes of Healthregenerative medicine, biomimetic, tissue engineering, biology, novel models, innovationPAR-22-0995/6/20246/5/2024
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)National Institutes of HealthMicrobiome, imaging, therapy, immune response, preclinical, bacteria, PAR-22-0856/5/2024
Biology of Bladder Cancer (R01 Clinical Trial Optional)National Institutes of Healthbiology, genetics, novel interventions, PAR-22-2185/6/20246/5/2024
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)National Institutes of HealthInnovation, population research, occupation, work-place, disparities, diversity, socialPAR-21-2756/5/2024
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)National Institutes of Healthcollaborative, therapies, basic, translational, clinical, biomarkers, PAR-21-3295/6/20246/5/2024
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)National Institutes of HealthInnovation, patient-clinician, communication, disparities, diversity, outcomes, equityPAR-22-0646/5/2024
Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)National Institutes of HealthSurvivor, treatment, diversity, observationalPAR-23-2925/6/20246/5/2024
Short-Term Research Education Program to Enhance Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)National Institutes of Healtheducation, skills development, biomedical, development, predoctoral, postdoctoralRFA-HL-25-0015/6/20246/5/2024
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)National Institutes of Healthcancer imaging, inflammation, molecular imaging, PET, MRI, biomarkers, diagnosis, prognosisPAR-21-2945/6/20246/5/2024
Addressing Health and Health Care Disparities among Sexual and Gender Minority Populations (R01 - Clinical Trials Optional)National Institutes of HealthHealth disparities, sexual and gender minorities (SGM), mental health, substance use, access to care, social determinants of healthPAR-24-0776/5/2024
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)National Institutes of Healthneuroscience, chemical probes, in vivo studies, drug discovery, neurotransmitters, brain imagingPAR-24-0886/5/2024
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)National Institutes of Healthclinical trials, early phase, treatment, diagnosis, innovative therapiesPAR-24-0851/5/20246/5/2024
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)National Institutes of Healthcancer prevention, clinical trials, intervention, lifestyle factors, environmental exposuresPAR-24-0725/6/20246/5/2024
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed?National Institutes of Healthglobal health, career development, collaborative researchPAR-24-1135/5/20246/5/2024
AHRQ Health Services Research Projects (R01)National Institutes of Healthequity, health servicesPA-24-1546/5/2024
Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01- Clinical Trial Optional)National Institutes of Health health disparities, long-term effects, disasters, healthcare systems, populationsPAR-24-1095/6/20246/5/2024
(NOSI): Administrative Supplements for Assessing and Enhancing Survivorship CareNational Institutes of Health NOSI, survivor, health disparities, Admin SuppNOT-CA-24-0356/5/2024
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)National Institutes of Health brain,monitoring, measurement, clinical R01PAR-24-1606/5/2024
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)National Institutes of HealthClinical, biology, biomarker, clinicalPAR-22-0495/8/20246/7/2024
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)National Institutes of HealthExploratory, Early-stage, cancer control, novel, ESIPAR-21-3415/8/20246/7/2024
(NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote HealthNational Institutes of Health patient adherence, treatment adherence, prevention adherence, health outcomes, R01,R21,R03,R41/R42,R43/R44,R21/R33,UG3/UH3,R34NOT-OD-21-1006/7/2024
Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumulation in Tauopathies (R01 Clinical Trial Not Allowed)National Institutes of Health genetics, protien, biology, mechanisms, early stageR01RFA-AG-25-0175/10/20246/10/2024
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)National Institutes of HealthDiversity, Research Scientist Development, Clinical TrialPAR-21-2956/12/2024
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)National Institutes of HealthDiversity, Research Scientist Development, Clinical Trial, ESIPAR-21-2996/12/2024
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)National Institutes of HealthDiversity, Early-stage, training, career transition, postdoctoral, biomedical, ESIPAR-21-3016/12/2024
NCI Transition Career Development Award to Promote Diversity (K22  Clinical Trial Required)National Institutes of HealthClinical Trials, Diversity, Early-stage, Career Transition, postdoctoral, ESIPAR-21-3026/12/2024
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)National Institutes of HealthClinical Trials, Early-stage, diagnosis, precention, disparities, molecules, xenograft, biology, ESIPAR-22-2166/12/2024
The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)National Institutes of Health cancer research, tenure-track faculty position, mentored research training, career development, clinical trialsPAR-24-1176/12/2024
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)National Institutes of Healthearly-stage, postdoctoral, cancer control, cancer prevention, data sciencePAR-23-2866/14/2024
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)National Institutes of Healthearly-stage, postdoctoral, cancer control, cancer prevention, data sciencePAR-23-2876/14/2024
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)National Institutes of Healthearly-stage, postdoctoral, cancer control, cancer prevention, data sciencePAR-23-2886/14/2024
BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed)National Institutes of Health Scaled Reagent Resources, Brain Cell Type-Specific Access, Vertebrate Species, U01 Clinical Trial Not AllowedRFA-MH-25-1005/15/20246/14/2024
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)National Institutes of HealthMechanisms, Incretin mimetics, Clinical trial not allowedPAR-23-2805/17/20246/16/2024
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)National Institutes of HealthHealth Equity Research, Cancer Disparities, Specifically named cancers (Various Cancer Types), Community ExposuresPAR-23-2556/16/2024
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)National Institutes of HealthInvestigator-Initiated Research, surgery, early-stagePAR-21-3325/17/20246/16/2024
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed)National Institutes of HealthCancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research, PAR-21-3246/16/2024
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)National Institutes of HealthCancer Genetics, Disparitites, biology, cancer prevenetion, novel strategies, basic research, PAR-21-3236/16/2024
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)National Institutes of Healthmicrobiome, immune response, novel molecules, early-stagePAR-22-0626/16/2024
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)National Institutes of HealthMicrobiome, imaging, therapy, immune response, preclinical, bacteria, exploratoryPAR-22-0866/16/2024
Biology of Bladder Cancer (R21 Clinical Trial Optional)National Institutes of HealthExploratory, biology, genetics, novel interventions, PAR-22-2195/17/20246/16/2024
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)National Institutes of Healthimmunity, immunological memory, immune systemPAR-24-1125/17/20246/16/2024
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)National Institutes of Health brain, biology, monitoring R21PAR-24-1616/16/2024
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)National Institutes of Healthearly- career, training, basic PAR-24-0396/18/2024
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)National Institutes of Healthhealth disparities, community, U34RFA-AA-24-0065/19/20246/18/2024
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)National Institutes of HealthSystems-level, mechanisms of responses. Therapy, novel, data, PAR-22-2345/21/20246/20/2024
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)National Institutes of Healthmind-body interventions, clinical trials, feasibility studies, multi-site research, chronic pain, stress managementPAR-24-0836/20/2024
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)National Institutes of Health mind-body interventions, clinical trials, feasibility studies,PAR-24-0846/20/2024
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)National Institutes of HealthComplementary and integrative health, remote interventions, mHealth, clinical trials (required)PAR-24-0865/21/20246/20/2024
(NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTechNational Institutes of Health medical devices, chronic pain, opioid use disorder, NIH HEAL InitiativeU44,UG3/UH3NOT-NS-23-0026/20/2024
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)National Institutes of Healthclinical, multi-site, data, centerPAR-24-1255/22/20246/21/2024
Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)National Institutes of Health brain, biology, monitoring R01RFA-NS-25-0146/24/2024
Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)National Institutes of Healthdata, natural products, intergrative,R01RFA-AT-24-0085/28/20246/28/2024
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional)National Institutes of HealthEarly-stage, innovation, ESI PA-21-1387/1/2024
Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional)National Institutes of Healthtransdisciplinary, physician, chemistry, biology, innovation, theory,PAR-22-1476/1/20247/1/2024
Assessment of Climate at Institutions (ACt) Award (RC2 - Clinical Trial Not Allowed)National Institutes of HealthDiversity, equity, and inclusion (DEIA), faculty hiring and advancement, institutional climate, surveys, action plansPAR-24-0386/1/20247/1/2024
(NOSI): Research supplements to promote workforce diversity and enhance utility and use of Common Fund datasetsNational Institutes of Health Workforce Diversity, Common Fund DatasetsNOT-RM-24-0037/1/2024
Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)National Institutes of Health consortium, palliative care, research, lifespan, serious illness, health disparitiesRFA-AG-25-0025/31/20247/2/2024
Advancing Genomic Medicine Research (R01 Clinical Trial Optional)National Institutes of Healthinnovation, health disparities, genomic information, early-stage, RFA-HG-23-0327/8/2024
Advancing Genomic Medicine Research (R21 Clinical Trial Optional)National Institutes of Healthinnovation, health disparities, genomic information, early-stage, RFA-HG-23-0337/8/2024
Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)National Institutes of Health investigator-initiated research, genomics, health equityRFA-HG-23-0186/8/20247/8/2024
Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)National Institutes of Health translational, diet, supplement RMIRFA-OD-24-0146/7/20247/8/2024
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)National Institutes of HealthDiversity, Research Scientist Development, Clinical TrialPAR-21-2967/12/2024
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required )National Institutes of HealthEarly-Stage, Tobacco, postdoctoral, RFA-OD-22-0265/12/20247/12/2024
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)National Institutes of Health therapeutics, genomics, genetics, early stage U01RFA-RM-24-0076/26/20247/26/2024
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)National Institutes of HealthEstablished, epidemiology, cancer controlPAR-22-1627/29/2024
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)National Institutes of Healthepidemiology, diversity, risks, rural, poverty, population-based research, cohortPAR-22-1617/29/2024
Multi-sectoral preventive interventions that address social determinants of health in populations that experience health disparities (UG3/UH3, Clinical Trial Required)National Institutes of Healthprevention, health disparities, network, innovation, PAR-24-0537/5/20248/5/2024
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)National Institutes of HealthEarly-stage, predoctoral, training, clinical, fellowship, physician PA-23-2608/8/2024
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)National Institutes of HealthEarly-stage, predoctoral, training, clinical, fellowship, physician PA-23-2728/8/2024
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)National Institutes of HealthEarly-stage, predoctoral, training, clinical, fellowship, physician, Diversity, PA-21-0528/8/2024
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)National Institutes of HealthFellowship, Postdoctoral, early-stage, mentor, PA-23-2628/8/2024
NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)National Institutes of Health early career, innovation DP2RFA-RM-24-0038/19/2024
NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)National Institutes of HealthNanotechnology, Brain Disorders, Biomedical Systems, BiomarkersRFA-RM-24-0049/3/2024
Notice of Special Interest (NOSI): Quantum Sensing in Biomedical Applications (SBIR/STRR)National Institutes of Health quantum sensing, biomedicine, National Institutes of Health (NIH), healthcare, novel imaging systems, early disease detectionR43/R44,R41/R42NOT-EY-23-0099/5/2024
NIH Director’s Early Independence Awards (DP5 Clinical Trial Optional)National Institutes of Health early career, LimitedDP5RFA-RM-24-0058/6/20249/6/2024
(NOSI): Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and OutcomesNational Institutes of Health R01,R03,R21NOT-AA-21-0289/7/2024
NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)National Institutes of HealthEarly Independence Awards, Small Research Grants, Digital Pathomics, Investigator-Initiated ResearchRFA-RM-24-0029/9/2024
(NOSI): Precision Imaging of Oral LesionsNational Institutes of Health oral lesions, imaging, diagnosis, treatmentR21,R01NOT-DE-21-0109/9/2024
(NOSI): Development and Preliminary Testing of Health-related Behavioral InterventionsNational Institutes of Health behavioral interventions, health, development, and testingR01,R34,R21,UG3/UH3,R61/R33,U54,U01,R21/R33NOT-OD-22-2039/26/2024
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)National Institutes of HealthDiversity, training, bioengineering, imaging, innovation, education, RFA-EB-23-0068/31/20249/30/2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)National Institutes of Healthmolecular, biomarkers, therapies, clinical PAR-23-31410/8/2024
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)National Institutes of Healthmolecular, biomarkers, therapies, clinical PAR-23-31310/8/2024
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)National Institutes of Healtheducation, skills development, biomedical, development, predoctoral, postdoctoralPAR-23-22210/11/2024
(NOSI): Administrative Supplements for Research on Womens Health in the IDeA StatesNational Institutes of Health women's health, IDeA states, health disparities, administrative supplementsAdmin SuppNOT-GM-22-00510/17/2024
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)National Institutes of HealthGut, Diet, lipids, biochemistry, biology, PAR-23-0519/23/202410/23/2024
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)National Institutes of HealthGut, Diet, lipids, biology, early-stage, biochemistryPAR-23-0529/26/202410/26/2024
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of HealthResearch Specialist, Laboratory-based ScientistPAR-23-24210/2/202411/1/2024
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)National Institutes of HealthResearch Specialist, Core-based Scientist, ESIPAR-23-24310/2/202411/1/2024
(NOSI): Mentored Career Development Awards to Foster the Careers of Investigators Pursuing Research Related to Down syndrome as Part of the INCLUDE ProjectNational Institutes of Health Mentored Career Development INCLUDE Project, Down Syndrome, ResearchK99/R00,K23,K08,K01,K43,UE5NOT-OD-22-12411/12/2024
(NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed)National Institutes of Health health disparities, Asian Americans, Native Hawaiians, Pacific Islanders, National Institutes of Health (NIH), cancer, cardiovascular disease, agingR21,R01NOT-HL-23-00111/18/2024
(NOSI): Stimulating Research to Understand and Address Hunger, Food and Nutrition InsecurityNational Institutes of Health Hunger, Food Insecurity, Nutrition Insecurity, ResearchR01,Admin Supp,R21,K01,R34,R33,R61/R33,UG3/UH3,K43NOT-OD-22-13511/28/2024
(NOSI): Accelerating Progress in Celiac Disease ResearchNational Institutes of Health  celiac disease, research, gluten-free dietR03,R21,U01,U44,R01,R34,P01,R61/R33NOT-AI-22-0041/7/2025
(NOSI): Biologic Factors Underlying Dental, Oral, and Craniofacial Health DisparitiesNational Institutes of Health dental, oral, craniofacial, health disparities, biological factors, R21,R01NOT-DE-21-0131/7/2025
(NOSI): SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)National Institutes of Health SBIR, technology transfer, NIH research programs, commercialization, neurological disorders, vision disorders, cancerR43/R44NOT-NS-22-0171/7/2025
(NOSI): Research Council of Finland (RCF) National Institutes of Health (NIH) Partnership ProgramNational Institutes of Health collaborative researchR01NOT-OD-24-0401/7/2025
?(NOSI): Competitive Revision Supplements to Existing T32 Programs to Include Institutional Research Training in Data Science for Infectious and Immune Mediated DiseasesNational Institutes of HealthTraining, clinical, biomedical, innovation, NOT-AI-24-0121/8/2025
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25 Clinical Trial Not Allowed)National Institutes of HealthUndergraduate, diversity, bioengineering, STEM, Early-stagePAR-23-11412/17/20241/17/2025
Advancing Research Careers (ARC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)National Institutes of Healtheducation, skills development, biomedical, development, predoctoral, postdoctoralPAR-23-22111/5/20231/29/2025
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)National Institutes of Healthdiabetes, kidney diseases, digestive and blood diseases, education programs, training, curriculum developmentPAR-24-0741/30/2025
(NOSI): Administrative Supplements to Prepare Data Assets for Infectious and Immune-mediated Diseases for Inclusion into the NIAID Data EcosystemNational Institutes of Health infectious diseases, immune-mediated diseases, data assets, NIAID Data Ecosystem, metadata, FAIR Guiding PrinciplesAdmin SuppNOT-AI-23-0092/13/2025
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)National Institutes of HealthBiomedical Research, Biomedical Informatics, Scholarly Works, Health InformaticsPAR-23-1831/27/20252/26/2025
(NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional)National Institutes of Health Community-Based, Participatory Research, Health Disparities, Down SyndromeR21NOT-OD-22-1423/16/2025
NCMRR Early Career Research Award (R03 Clinical Trial Optional)National Institutes of HealthBiomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchPAR-23-0293/28/2025
(NOSI): Developing Academic Research Enhancement Award (AREA) and Research Enhancement Award Program (REAP) for Institutions with an emphasis on Down syndrome research (R15 Clinical Trial Not Allowed)National Institutes of Health  Research Enhancement , Down Syndrome R15NOT-OD-22-1364/10/2025
(NOSI): Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)National Institutes of Health Administrative Supplements, Analytical Methods, Dietary Supplement ConstituentsAdmin SuppNOT-OD-22-2024/15/2025
(NOSI): NIH Research Project Grants on Down Syndrome (R01) for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project National Institutes of Health INCLUDE Project, Down Syndrome, Co-occurring Conditions, LifespanR01NOT-OD-22-1234/30/2025
(NOSI): Climate Change and HealthNational Institutes of Health climate change, health, NIH Climate Change and Health InitiativeR21,F31,D43,K01,R03,K43,K99/R00,U01,U19,R01,F32,K23,F30,R21/R33NOT-ES-22-0065/7/2025
(NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the LifespanNational Institutes of Health Evidence-Based Screening, health Disparities, LifespanR03,R01,R34,R21,UG3/UH3,R61/R33,Admin SuppNOT-OD-22-1065/7/2025
(NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the LifespanNational Institutes of Health Health Disparities, Evidence-based, lifespanR21,R01,UG3/UH3,R61/R33,R34,R03NOT-OD-22-1785/7/2025
Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]National Institutes of Health Predoctoral Training, Advanced Data Analytics, Behavioral and Social Sciences Research (BSSR), Institutional Research Training Program, T32RFA-OD-24-0125/24/2025
(NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) ProjectNational Institutes of Health Administrative Supplements, INCLUDE Project, Down SyndromeAdmin Supp,NOT-OD-22-1376/1/2025
(NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic DiscoveryNational Institutes of Health pain research, pain measurement, non-addictive pain medications, chronic painR61/R33NOT-NS-22-0956/24/2025
(NOSI): Promoting Mechanistic Research on Therapeutic and Other Biological Properties of Minor Cannabinoids and TerpenesNational Institutes of Health minor cannabinoids, terpenes, cannabis, therapeutic benefits, pain, analgesia, inflammation, cancer, glaucoma, neurological disorders,R21,R01,UG3/UH3NOT-AT-22-0276/30/2025
(NOSI): Research on the Health of Sexual and Gender Minority (SGM) PopulationsNational Institutes of Health sexual and gender minority (SGM) health, social determinants of health, mental health, cancerR01,K08,K99/R00,K01,K23,R21,K25,K18,R03,P50,F99/K00,UG3/UH3,R34,R25,U01NOT-MD-22-0128/7/2025
(NOSI): Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and ScholarsNational Institutes of Health Administrative Supplements, Research Continuity, Retention, Mentored Career Development, K Award Recipients, ScholarsAdmin SuppNOT-OD-23-0319/30/2025
(NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant AwardsNational Institutes of Health Administrative Supplement, Biomedical, Behavioral Research, First-Time Recipients, Research Project Grant AwardsAdmin SuppNOT-OD-23-0329/30/2025
(NOSI): Health Influences of Gender as a Social and Structural VariableNational Institutes of Health Gender, Social Variable, Structural Variable, Health InfluencesK08,R01,K23,R21,K01,R03,F31,R34NOT-OD-24-0389/30/2025
(NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant AwardsNational Institutes of Health NOSI, health disparities, biomedical, behavioral, communication NOT-OD-23-03210/1/2025
(NOSI): Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and ScholarsNational Institutes of Health supplement, early career, development, scholar, NOT-OD-23-03110/1/2025
(NOSI): Health Influences of Gender as a Social and Structural VariableNational Institutes of Health health disparities, social determinants, intervention research, NOSINOT-OD-24-03810/1/2025
(NOSI): Preventive Interventions to Address Cardiometabolic Risk Factors in Populations that Experience Health DisparitiesNational Institutes of Health Preventive Interventions, Cardiometabolic Risk Factors, Health DisparitiesR01,R21,R34,R03,UG3/UH3NOT-OD-22-15410/5/2025
BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)National Institutes of Health brain cell type-specific access reagents, brain circuit function, dissection of neural circuits, scalable production and distribution facilities, cell type-selective access reagents, BRAIN Initiative Armamentarium projectRFA-MH-25-10510/1/202510/31/2025
(NOSI): Advancing Development of Rapid Point-of-Care Hepatitis C Virus DiagnosticsNational Institutes of Health R01,R41/R42,R43/R44,R21NOT-AI-23-0011/7/2026
(NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic DiseasesNational Institutes of Health endocannabinoid system, ECS, cannabinoids, substance use, substance use disorder, SUD, physiological processes, analgesia, anti-inflammatory, nervous systemR01,R21,DP2,DP1,K99/R00,K01,R36,K08,R15,K24NOT-DA-22-0481/7/2026
(NOSI): Chemical Countermeasures Research Program (CCRP) Administrative Supplements to Promote the Development of Pediatric Research Models of Chemical Injury and Medical Countermeasures DiscoveryNational Institutes of Health supplement, pediatric, health disparities, injury, chemistry NOT-AI-24-0223/17/2026
(NOSI): Research on Family Support and Rejection in the Health and Well-Being of SGM PopulationsNational Institutes of Health sexual and gender minority (SGM), family support, family rejection, health, well-being, research, LGBTQI2S+, impact, consequencesR21,R15,R01,R34,K25,K99/R00,K01,R03,P01,K08,K23NOT-OD-23-1665/7/2026
(NOSI): Synthetic Biology for Biomedical Applications.National Institutes of Health synthetic biology, biomedical applicationsR01,R21,R35,R41/R42,R43/R44NOT-EB-23-0025/16/2026
(NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant PopulationsNational Institutes of Health immigrant health, health disparities, health advantages, social determinants of health, acculturation, biological factors, immigration policies, local contextsR01,R61/R33NOT-MD-23-0026/5/2026
(NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective InterventionsNational Institutes of Health immigrant health, health disparities, interventions, social determinants of health, immigration processR01NOT-MD-23-0036/5/2026
(NOSI): Research to Address Vaccine Uptake and Implementation among Populations Experiencing Health DisparitiesNational Institutes of Health vaccine hesitancy, vaccine uptake, vaccine implementation, health disparities,R01,R21NOT-MD-23-0086/5/2026
(NOSI): National Center for Complementary and Integrative Health (NCCIH) T32 Supplement Program to Promote Diversity in Health ResearchNational Institutes of HealthCenter, health disparties, NOT-AT-24-0349/3/2026
(NOSI): Epidemiology and Prevention in Alcohol ResearchNational Institutes of Health alcohol, epidemiology, prevention, researchR03,R21,R01,UG3/UH3,R61/R33NOT-AA-23-0189/5/2026
(NOSI): Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)National Institutes of Health Research Supplements, Re-entry, Re-integration, Re-training, Health-Related Research Careers, Clinical Trial Not AllowedAdmin SuppNOT-OD-23-17010/8/2026
(NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural CommunitiesNational Institutes of Health telehealth, rural communities, healthcare access, provider-to-provider telehealth (PPT), real-world effectiveness, implementationR01,R21NOT-HL-23-08310/9/2026
(NOSI): RNA Delivery Technologies to Allow Specific Tissue Target Homing (RNA-DASH)National Institutes of Health RNA-based therapeutics, delivery, non-viral, small business, pre-clinicalR43/R44,R41/R42NOT-AI-24-0071/5/2027
(NOSI): Data Informed, Place-Based Community-Engaged Research to Advance Health EquityNational Institutes of Health geospatial data, health disparities, place-based research, social determinants of health, community-engaged researchR01,R34,R21,UG3/UH3,K01,R03,P01,P50,K08,K23NOT-HL-23-1101/7/2027
(NOSI): Quantum Sensing Technologies in Biomedical ApplicationsNational Institutes of Health quantum sensing, biomedical applications, quantum technologiesR35,RM1,R21,R01,U01,R15,R13,K99/R00NOT-EB-23-0221/26/2027
(NOSI): Inborn Errors of Immunity/Primary ImmunodeficienciesNational Institutes of Health immunology, NOT-AI-24-0243/17/2027
(NOSI): Research to Stimulate Development of Diagnostics, Therapeutics, and Vaccines for Herpes Simplex Virus (HSV)?National Institutes of HealthDiagnostic, clinical and treatment methods, vaccinesNOT-AI-24-0284/6/2027
(NOSI): Development of Imaging Techniques for High Resolution and Functional Scanning of In Vivo Human Sensory and Communication SystemsNational Institutes of Health NOSI, imaging, technology, communication NOT-DC-24-0255/8/2027
(NOSI): Developing and Testing Multi-level Physical Activity Interventions to Improve Health and Well-Being?National Institutes of Health Physical Activity, Interventions, Health, Well-beingR01, R21, R03, R34, U24, UG3/UH3, NOT-OD-24-0589/14/2027

Can’t find what you’re looking for? Please contact researchdevelopment@cancer.ufl.edu for assistance in finding additional funding opportunities.

NCI Cancer Center badge